Funding for this research was provided by:
Wellcome Trust (091625, 096527)
Received: 5 December 2016
Accepted: 26 February 2018
First Online: 6 March 2018
Ethics approval and consent to participate
: RNP is the principal investigator of the IMPROV study. RNP, PYC and LvS are members of the IMPROV Trial Management Group. We declare no other interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.